Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116947597B reveals metal-free synthesis for o-iodophenyl acetylene. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing processes.
Patent CN111635370A details a green photocatalytic route for 3-alkylquinoxalinone derivatives, offering mild conditions and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable supply and cost-effective API intermediate manufacturing.
Patent CN115353511A details a novel multi-component Pd-catalyzed carbonylation for synthesizing indolinone-imidazole hybrids, offering cost-effective routes for API intermediates.
Patent CN112028841A reveals a catalyst-free visible light method for high-yield quinoxalinone synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111423381B details a mild Pd-catalyzed route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced cost efficiency.
Patent CN116143689A details a metal-free route to tetrasubstituted pyridines using imidazole hydrochloride, offering high yields and scalability for pharmaceutical intermediates.
Novel patent CN113651788B enables efficient room temperature synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity and cost-effective synthesis for asymmetric catalysis.
This patent details a novel one-step synthesis route for spiro pyrroloindolone derivatives offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes globally.
Patent CN118126005B reveals a metal-free route for fluorinated heterocycles, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN108610278A details Rh(III) catalyzed synthesis offering mild conditions and streamlined operations for cost reduction in fine chemical manufacturing supply chains.
Patent CN105175370A reveals a novel palladium-catalyzed route for Olaparib intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel palladium catalyzed synthesis offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for high purity pharmaceutical intermediates.
Patent CN111690947B details a metal-free electrochemical method for trifluoromethylation, offering green chemistry solutions and cost reduction in API manufacturing.
Patent CN112225657B reveals a green aqueous Suzuki coupling for Flurbiprofen. Discover cost-effective manufacturing and high-purity supply chain solutions.
Discover a novel method for synthesizing quinolizinone compounds using propiolates and pyridine derivatives. Offers high yields, mild conditions, and cost-effective manufacturing for pharmaceutical intermediates.
Novel iron-catalyzed asymmetric hydrogenation technology using chiral quinoline imidazoline ligands. Reduces noble metal dependency for high-purity pharmaceutical intermediates.
Novel carbonylation cyclization method for N-acyl indoles using solid CO sources. Enhances purity and scalability for pharmaceutical intermediate manufacturing.
Patent CN104662008A reveals novel tetrazole deprotection for Angiotensin II receptor blockers. Achieve cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.